A cross-disciplinary perspective on the innate immune responses to bacterial lipopolysaccharide

Molecular Cell

Volumn 54, Issue 2, 2014, Pages 212-223

  Tan, Yunhao ^a   Kagan, Jonathan C ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; LIPOPOLYSACCHARIDE BINDING PROTEIN; PROTEIN MD 2; TOLL LIKE RECEPTOR 4;

BACTERIAL IMMUNITY; BACTERIAL INFECTION; BACTERIAL VIRULENCE; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; IMMUNE EVASION; IMMUNE RESPONSE; INNATE IMMUNITY; NONHUMAN; PROTEIN ANALYSIS; REVIEW; SIGNAL TRANSDUCTION; TYPE III SECRETION SYSTEM;

ANIMALS; GRAM-NEGATIVE BACTERIA; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; LIPOPOLYSACCHARIDES; MICE; MODELS, IMMUNOLOGICAL; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84899137757     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2014.03.012     Document Type: Review

References (107)

1. Aachoui Y., Leaf I.A., Hagar J.A., Fontana M.F., Campos C.G., Zak D.E., Tan M.H., Cotter P.A., Vance R.E., Aderem A., Miao E.A. Caspase-11 protects against bacteria that escape the vacuole. Science 2013, 339:975-978.
2. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
3. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 2001, 29:1303-1310.
4. Arbibe L., Kim D.W., Batsche E., Pedron T., Mateescu B., Muchardt C., Parsot C., Sansonetti P.J. An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses. Nat. Immunol. 2007, 8:47-56.
5. Barbalat R., Lau L., Locksley R.M., Barton G.M. Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat. Immunol. 2009, 10:1200-1207.
6. Barbero P., Bittova L., Pfeffer S.R. Visualization of Rab9-mediated vesicle transport from endosomes to the trans-Golgi in living cells. J.Cell Biol. 2002, 156:511-518.
7. Barton G.M., Kagan J.C., Medzhitov R. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat. Immunol. 2006, 7:49-56.
8. Beutler B. Tlr4: central component of the sole mammalian LPS sensor. Curr. Opin. Immunol. 2000, 12:20-26.
9. Beutler B., Du X., Poltorak A. Identification of Toll-like receptor 4 (Tlr4) as the sole conduit for LPS signal transduction: genetic and evolutionary studies. J.Endotoxin Res. 2001, 7:277-280.
10. Bonham K.S., Orzalli M.H., Hayashi K., Wolf A.I., Glanemann C., Weninger W., Iwasaki A., Knipe D.M., Kagan J.C. A promiscuous lipid-binding protein diversifies the subcellular sites of toll-like receptor signal transduction. Cell 2014, 156:705-716.
11. Brennan D.F., Barford D. Eliminylation: a post-translational modification catalyzed by phosphothreonine lyases. Trends Biochem. Sci. 2009, 34:108-114.
12. Chiang C.Y., Veckman V., Limmer K., David M. Phospholipase Cγ-2 and intracellular calcium are required for lipopolysaccharide-induced Toll-like receptor 4 (TLR4) endocytosis and interferon regulatory factor 3 (IRF3) activation. J.Biol. Chem. 2012, 287:3704-3709.
13. Chinnapen D.J., Chinnapen H., Saslowsky D., Lencer W.I. Rafting with cholera toxin: endocytosis and trafficking from plasma membrane to ER. FEMS Microbiol. Lett. 2007, 266:129-137.
14. Coats S.R., Jones J.W., Do C.T., Braham P.H., Bainbridge B.W., To T.T., Goodlett D.R., Ernst R.K., Darveau R.P. Human Toll-like receptor 4 responses to P. gingivalis are regulated by lipid A 1- and 4'-phosphatase activities. Cell. Microbiol. 2009, 11:1587-1599.
15. Cohen J. The immunopathogenesis of sepsis. Nature 2002, 420:885-891.
16. Coutinho A., Forni L., Melchers F., Watanabe T. Genetic defect in responsiveness to the B cell mitogen lipopolysaccharide. Eur. J. Immunol. 1977, 7:325-328.
17. Dixit E., Boulant S., Zhang Y., Lee A.S., Odendall C., Shum B., Hacohen N., Chen Z.J., Whelan S.P., Fransen M., et al. Peroxisomes are signaling platforms for antiviral innate immunity. Cell 2010, 141:668-681.
18. Drecktrah D., Knodler L.A., Howe D., Steele-Mortimer O. Salmonella trafficking is defined by continuous dynamic interactions with the endolysosomal system. Traffic 2007, 8:212-225.
19. Ewald S.E., Lee B.L., Lau L., Wickliffe K.E., Shi G.P., Chapman H.A., Barton G.M. The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Nature 2008, 456:658-662.
20. Figueira R., Holden D.W. Functions of the Salmonella pathogenicity island 2 (SPI-2) type III secretion system effectors. Microbiology 2012, 158:1147-1161.
21. Frey E.A., Miller D.S., Jahr T.G., Sundan A., Bazil V., Espevik T., Finlay B.B., Wright S.D. Soluble CD14 participates in the response ofcells to lipopolysaccharide. J.Exp. Med. 1992, 176:1665-1671.
22. Gerard C. Bacterial infection. For whom the bell tolls. Nature 1998, 395:217-219.
23. Gerth A., Grosche J., Nieber K., Hauschildt S. Intracellular LPS inhibits the activity of potassium channels and fails to activate NFkappaB in human macrophages. J.Cell. Physiol. 2005, 202:442-452.
24. Giardina P.C., Gioannini T., Buscher B.A., Zaleski A., Zheng D.S., Stoll L., Teghanemt A., Apicella M.A., Weiss J. Construction of acetate auxotrophs of Neisseria meningitidis to study host-meningococcal endotoxin interactions. J.Biol. Chem. 2001, 276:5883-5891.
25. Gioannini T.L., Weiss J.P. Regulation of interactions of Gram-negative bacterial endotoxins with mammalian cells. Immunol. Res. 2007, 39:249-260.
26. Gioannini T.L., Teghanemt A., Zhang D., Coussens N.P., Dockstader W., Ramaswamy S., Weiss J.P. Isolation of an endotoxin-MD-2 complex that produces Toll-like receptor 4-dependent cell activation at picomolar concentrations. Proc. Natl. Acad. Sci. USA 2004, 101:4186-4191.
27. Gioannini T.L., Teghanemt A., Zhang D., Levis E.N., Weiss J.P. Monomeric endotoxin:protein complexes are essential for TLR4-dependent cell activation. J.Endotoxin Res. 2005, 11:117-123.
28. Golenbock D.T., Hampton R.Y., Qureshi N., Takayama K., Raetz C.R. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J.Biol. Chem. 1991, 266:19490-19498.
29. Guo L., Lim K.B., Gunn J.S., Bainbridge B., Darveau R.P., Hackett M., Miller S.I. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 1997, 276:250-253.
30. Guo L., Lim K.B., Poduje C.M., Daniel M., Gunn J.S., Hackett M., Miller S.I. Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell 1998, 95:189-198.
31. Hagar J.A., Powell D.A., Aachoui Y., Ernst R.K., Miao E.A. Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock. Science 2013, 341:1250-1253.
32. Hang H.C., Loureiro J., Spooner E., van der Velden A.W., Kim Y.M., Pollington A.M., Maehr R., Starnbach M.N., Ploegh H.L. Mechanism-based probe for the analysis of cathepsin cysteine proteases in living cells. ACS Chem. Biol. 2006, 1:713-723.
33. Haziot A., Chen S., Ferrero E., Low M.G., Silber R., Goyert S.M. The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J.Immunol. 1988, 141:547-552.
34. Haziot A., Ferrero E., Köntgen F., Hijiya N., Yamamoto S., Silver J., Stewart C.L., Goyert S.M. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 1996, 4:407-414.
35. Haziot A., Hijiya N., Gangloff S.C., Silver J., Goyert S.M. Induction of a novel mechanism of accelerated bacterial clearance by lipopolysaccharide in CD14-deficient and Toll-like receptor 4-deficient mice. J.Immunol. 2001, 166:1075-1078.
36. Heppner G., Weiss D.W. High susceptibility of Strain A mice to endotoxin and endotoxin-red blood cell mixtures. J.Bacteriol. 1965, 90:696-703.
37. Hernandez L.D., Hueffer K., Wenk M.R., Galán J.E. Salmonella modulates vesicular traffic by altering phosphoinositide metabolism. Science 2004, 304:1805-1807.
38. Horner S.M., Liu H.M., Park H.S., Briley J., Gale M. Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proc. Natl. Acad. Sci. USA 2011, 108:14590-14595.
39. Horng T., Barton G.M., Flavell R.A., Medzhitov R. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 2002, 420:329-333.
40. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J.Immunol. 1999, 162:3749-3752.
41. Isberg R.R., O'Connor T.J., Heidtman M. The Legionella pneumophila replication vacuole: making a cosy niche inside host cells. Nat. Rev. Microbiol. 2009, 7:13-24.
42. Jiang Z., Georgel P., Du X., Shamel L., Sovath S., Mudd S., Huber M., Kalis C., Keck S., Galanos C., et al. CD14 is required for MyD88-independent LPS signaling. Nat. Immunol. 2005, 6:565-570.
43. Kagan J.C. Signaling organelles of the innate immune system. Cell 2012, 151:1168-1178.
44. Kagan J.C. Defining the subcellular sites of innate immune signal transduction. Trends Immunol. 2012, 33:442-448.
45. Kagan J.C., Medzhitov R. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 2006, 125:943-955.
46. Kagan J.C., Stein M.P., Pypaert M., Roy C.R. Legionella subvert the functions of Rab1 and Sec22b to create a replicative organelle. J.Exp. Med. 2004, 199:1201-1211.
47. Kagan J.C., Su T., Horng T., Chow A., Akira S., Medzhitov R. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat. Immunol. 2008, 9:361-368.
48. Kawahara K., Tsukano H., Watanabe H., Lindner B., Matsuura M. Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperature. Infect. Immun. 2002, 70:4092-4098.
49. Kayagaki N., Warming S., Lamkanfi M., Vande Walle L., Louie S., Dong J., Newton K., Qu Y., Liu J., Heldens S., et al. Non-canonical inflammasome activation targets caspase-11. Nature 2011, 479:117-121.
50. Kayagaki N., Wong M.T., Stowe I.B., Ramani S.R., Gonzalez L.C., Akashi-Takamura S., Miyake K., Zhang J., Lee W.P., Muszyński A., et al. Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 2013, 341:1246-1249.
51. Kim H.M., Park B.S., Kim J.I., Kim S.E., Lee J., Oh S.C., Enkhbayar P., Matsushima N., Lee H., Yoo O.J., Lee J.O. Crystal structure ofthe TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 2007, 130:906-917.
52. Lamkanfi M., Dixit V.M. Inflammasomes and their roles in health and disease. Annu. Rev. Cell Dev. Biol. 2012, 28:137-161.
53. Li X.D., Sun L., Seth R.B., Pineda G., Chen Z.J. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc. Natl. Acad. Sci. USA 2005, 102:17717-17722.
54. Li H., Xu H., Zhou Y., Zhang J., Long C., Li S., Chen S., Zhou J.M., Shao F. The phosphothreonine lyase activity of a bacterial type III effector family. Science 2007, 315:1000-1003.
55. McGourty K., Thurston T.L., Matthews S.A., Pinaud L., Mota L.J., Holden D.W. Salmonella inhibits retrograde trafficking of mannose-6-phosphate receptors and lysosome function. Science 2012, 338:963-967.
56. Medzhitov R. Approaching the asymptote: 20 years later. Immunity 2009, 30:766-775.
57. Medzhitov R., Preston-Hurlburt P., Janeway C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394-397.
58. Meng J., Gong M., Björkbacka H., Golenbock D.T. Genome-wide expression profiling and mutagenesis studies reveal that lipopolysaccharide responsiveness appears to be absolutely dependent on TLR4 and MD-2expression and is dependent upon intermolecular ionic interactions. J.Immunol. 2011, 187:3683-3693.
59. Miyake K., Yamashita Y., Hitoshi Y., Takatsu K., Kimoto M. Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells. J.Exp. Med. 1994, 180:1217-1224.
60. Montminy S.W., Khan N., McGrath S., Walkowicz M.J., Sharp F., Conlon J.E., Fukase K., Kusumoto S., Sweet C., Miyake K., et al. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nat. Immunol. 2006, 7:1066-1073.
61. Moran A.P., Lindner B., Walsh E.J. Structural characterization ofthe lipid A component of Helicobacter pylori rough- and smooth-form lipopolysaccharides. J.Bacteriol. 1997, 179:6453-6463.
62. Mukherjee S., Keitany G., Li Y., Wang Y., Ball H.L., Goldsmith E.J., Orth K. Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 2006, 312:1211-1214.
63. Nagai H., Kagan J.C., Zhu X., Kahn R.A., Roy C.R. A bacterial guanine nucleotide exchange factor activates ARF on Legionella phagosomes. Science 2002, 295:679-682.
64. Nagai Y., Akashi S., Nagafuku M., Ogata M., Iwakura Y., Akira S., Kitamura T., Kosugi A., Kimoto M., Miyake K. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 2002, 3:667-672.
65. Newton C.A., Perkins I., Widen R.H., Friedman H., Klein T.W. Role of Toll-like receptor 9 in Legionella pneumophila-induced interleukin-12 p40 production in bone marrow-derived dendritic cells and macrophages from permissive and nonpermissive mice. Infect. Immun. 2007, 75:146-151.
66. Ohto U., Fukase K., Miyake K., Satow Y. Crystal structures ofhuman MD-2 and its complex with antiendotoxic lipid IVa. Science 2007, 316:1632-1634.
67. Orth K., Palmer L.E., Bao Z.Q., Stewart S., Rudolph A.E., Bliska J.B., Dixon J.E. Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector. Science 1999, 285:1920-1923.
68. Orth K., Xu Z., Mudgett M.B., Bao Z.Q., Palmer L.E., Bliska J.B., Mangel W.F., Staskawicz B., Dixon J.E. Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease. Science 2000, 290:1594-1597.
69. Paciello I., Silipo A., Lembo-Fazio L., Curcurù L., Zumsteg A., Noël G., Ciancarella V., Sturiale L., Molinaro A., Bernardini M.L. Intracellular Shigella remodels its LPS to dampen the innate immune recognition and evade inflammasome activation. Proc. Natl. Acad. Sci. USA 2013, 110:E4345-E4354.
70. Palmer L.E., Hobbie S., Galán J.E., Bliska J.B. YopJ of Yersinia pseudotuberculosis is required for the inhibition of macrophage TNF-alpha production and downregulation of the MAP kinases p38 and JNK. Mol. Microbiol. 1998, 27:953-965.
71. Park B., Brinkmann M.M., Spooner E., Lee C.C., Kim Y.M., Ploegh H.L. Proteolytic cleavage in an endolysosomal compartment is required foractivation of Toll-like receptor 9. Nat. Immunol. 2008, 9:1407-1414.
72. Park B.S., Song D.H., Kim H.M., Choi B.S., Lee H., Lee J.O. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 2009, 458:1191-1195.
73. Perera P.Y., Vogel S.N., Detore G.R., Haziot A., Goyert S.M. CD14-dependent and CD14-independent signaling pathways in murine macrophages from normal and CD14 knockout mice stimulated with lipopolysaccharide or taxol. J.Immunol. 1997, 158:4422-4429.
74. Perry R.D., Fetherston J.D. Yersinia pestis-etiologic agent of plague. Clin. Microbiol. Rev. 1997, 10:35-66.
75. Phillips N.J., Schilling B., McLendon M.K., Apicella M.A., Gibson B.W. Novel modification of lipid A of Francisella tularensis. Infect. Immun. 2004, 72:5340-5348.
76. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088.
77. Poltorak A., Smirnova I., He X., Liu M.Y., Van Huffel C., McNally O., Birdwell D., Alejos E., Silva M., Du X., et al. Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol. Dis. 1998, 24:340-355.
78. Prohinar P., Re F., Widstrom R., Zhang D., Teghanemt A., Weiss J.P., Gioannini T.L. Specific high affinity interactions of monomeric endotoxin.protein complexes with Toll-like receptor 4 ectodomain. J.Biol. Chem. 2007, 282:1010-1017.
79. Pugin J., Schürer-Maly C.C., Leturcq D., Moriarty A., Ulevitch R.J., Tobias P.S. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA 1993, 90:2744-2748.
80. Raetz C.R., Reynolds C.M., Trent M.S., Bishop R.E. Lipid A modification systems in gram-negative bacteria. Annu. Rev. Biochem. 2007, 76:295-329.
81. Rangarajan M., Aduse-Opoku J., Paramonov N., Hashim A., Bostanci N., Fraser O.P., Tarelli E., Curtis M.A. Identification of a second lipopolysaccharide in Porphyromonas gingivalis W50. J.Bacteriol. 2008, 190:2920-2932.
82. Rebeil R., Ernst R.K., Gowen B.B., Miller S.I., Hinnebusch B.J. Variation in lipid A structure in the pathogenic yersiniae. Mol. Microbiol. 2004, 52:1363-1373.
83. Rietschel E.T., Kirikae T., Schade F.U., Mamat U., Schmidt G., Loppnow H., Ulmer A.J., Zähringer U., Seydel U., Di Padova F., et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 1994, 8:217-225.
84. Rowe D.C., McGettrick A.F., Latz E., Monks B.G., Gay N.J., Yamamoto M., Akira S., O'Neill L.A., Fitzgerald K.A., Golenbock D.T. The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction. Proc. Natl. Acad. Sci. USA 2006, 103:6299-6304.
85. Sandström G., Sjöstedt A., Johansson T., Kuoppa K., Williams J.C. Immunogenicity and toxicity of lipopolysaccharide from Francisella tularensis LVS. FEMS Microbiol. Immunol. 1992, 5:201-210.
86. Sasai M., Linehan M.M., Iwasaki A. Bifurcation of Toll-like receptor 9 signaling by adaptor protein 3. Science 2010, 329:1530-1534.
87. Schumann R.R., Leong S.R., Flaggs G.W., Gray P.W., Wright S.D., Mathison J.C., Tobias P.S., Ulevitch R.J. Structure and function of lipopolysaccharide binding protein. Science 1990, 249:1429-1431.
88. Sherwood R.K., Roy C.R. A Rab-centric perspective of bacterial pathogen-occupied vacuoles. Cell Host Microbe 2013, 14:256-268.
89. Shimazu R., Akashi S., Ogata H., Nagai Y., Fukudome K., Miyake K., Kimoto M. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J.Exp. Med. 1999, 189:1777-1782.
90. Swanson M.S., Hammer B.K. Legionella pneumophila pathogesesis: a fateful journey from amoebae to macrophages. Annu. Rev. Microbiol. 2000, 54:567-613.
91. Terebiznik M.R., Vieira O.V., Marcus S.L., Slade A., Yip C.M., Trimble W.S., Meyer T., Finlay B.B., Grinstein S. Elimination of host cell PtdIns(4,5)P(2) by bacterial SigD promotes membrane fission during invasion by Salmonella. Nat. Cell Biol. 2002, 4:766-773.
92. Tobias P.S., Soldau K., Ulevitch R.J. Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J.Exp. Med. 1986, 164:777-793.
93. Tobias P.S., Soldau K., Kline L., Lee J.D., Kato K., Martin T.P., Ulevitch R.J. Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein. J.Immunol. 1993, 150:3011-3021.
94. Triantafilou M., Miyake K., Golenbock D.T., Triantafilou K. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J.Cell Sci. 2002, 115:2603-2611.
95. Tseng T.T., Tyler B.M., Setubal J.C. Protein secretion systems in bacterial-host associations, and their description in the Gene Ontology. BMC Microbiol. 2009, 9(Suppl 1):S2.
96. Vinogradov E., Perry M.B., Conlan J.W. Structural analysis of Francisella tularensis lipopolysaccharide. Eur. J. Biochem. 2002, 269:6112-6118.
97. Viriyakosol S., Tobias P.S., Kitchens R.L., Kirkland T.N. MD-2 binds to bacterial lipopolysaccharide. J.Biol. Chem. 2001, 276:38044-38051.
98. Vogel S.N., Moore R.N., Sipe J.D., Rosenstreich D.L. BCG-induced enhancement of endotoxin sensitivity in C3H/HeJ mice. I. Invivo studies. J.Immunol. 1980, 124:2004-2009.
99. Wang S., Miura M., Jung Yk., Zhu H., Gagliardini V., Shi L., Greenberg A.H., Yuan J. Identification and characterization of Ich-3, a member of the interleukin-1beta converting enzyme (ICE)/Ced-3 family and an upstream regulator of ICE. J.Biol. Chem. 1996, 271:20580-20587.
100. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990, 249:1431-1433.
101. Yamamoto M., Sato S., Hemmi H., Sanjo H., Uematsu S., Kaisho T., Hoshino K., Takeuchi O., Kobayashi M., Fujita T., et al. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 2002, 420:324-329.
102. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., Takeuchi O., Sugiyama M., Okabe M., Takeda K., Akira S. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003, 301:640-643.
103. Yamamoto M., Sato S., Hemmi H., Uematsu S., Hoshino K., Kaisho T., Takeuchi O., Takeda K., Akira S. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat. Immunol. 2003, 4:1144-1150.
104. Zanoni I., Ostuni R., Capuano G., Collini M., Caccia M., Ronchi A.E., Rocchetti M., Mingozzi F., Foti M., Chirico G., et al. CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation. Nature 2009, 460:264-268.
105. Zanoni I., Ostuni R., Marek L.R., Barresi S., Barbalat R., Barton G.M., Granucci F., Kagan J.C. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 2011, 147:868-880.
106. Zanoni I., Ostuni R., Barresi S., Di Gioia M., Broggi A., Costa B., Marzi R., Granucci F. CD14 and NFAT mediate lipopolysaccharide-induced skin edema formation in mice. J.Clin. Invest. 2012, 122:1747-1757.
107. Zhou D., Galán J. Salmonella entry into host cells: the work inconcert of type III secreted effector proteins. Microbes Infect. 2001, 3:1293-1298.